Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Techno Medical PCL (BKK:TM-R) Capex-to-Revenue Explanation
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.
Techno Medical PCL Capex-to-Revenue Related Terms
Techno Medical PCL Capex-to-Revenue Historical Data
* Premium members only.
The historical data trend for Techno Medical PCL's Capex-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:TM-R vs MCK, COR, CAH: Capex-to-Revenue Comparison
For the Medical Distribution subindustry, Techno Medical PCL's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Medical PCL Capex-to-Revenue vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Techno Medical PCL's Capex-to-Revenue distribution charts can be found below:
* The bar in red indicates where Techno Medical PCL's Capex-to-Revenue falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Techno Medical PCL (BKK:TM-R) has a Capex-to-Revenue of 0.01 as of Mar. 2026. Capex to Revenue ratio measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. View historical data on Techno Medical PCL and its competitors.
Is Techno Medical PCL's Capex-to-Revenue too high?
Techno Medical PCL's current Capex-to-Revenue is 0.01. Overall, Techno Medical PCL has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Techno Medical PCL's Capex-to-Revenue compare to MCK and COR?
Techno Medical PCL's Capex-to-Revenue of 0.01 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Revenue for a Medical Distribution company?
A good Capex-to-Revenue depends on the Medical Distribution industry context. However, Capex-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Revenue mean?
A high Capex-to-Revenue can signal that a stock is expensive relative to its fundamentals. Capex to Revenue ratio measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. View historical data on Techno Medical PCL and its competitors. Techno Medical PCL's current Capex-to-Revenue is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medical PCL stock overvalued right now?
Techno Medical PCL (BKK:TM-R) has a current Capex-to-Revenue of 0.01. The stock's GF Value™ is ฿2.99, compared to a current price of ฿2.32 — trading 22.4% below its estimated fair value. The current Capex-to-Revenue is 0.01. Techno Medical PCL's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Revenue calculated?
Capex-to-Revenue is calculated from a company's financial statements. For Techno Medical PCL (BKK:TM-R), the current Capex-to-Revenue is 0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Techno Medical PCL (BKK:TM-R) Overvalued in 2026?
Based on GuruFocus' analysis, Techno Medical PCL stock appears to be undervalued.
The current stock price of ฿2.32 is trading 22.4% below its estimated GF Value™ of ฿2.99.
Key valuation signals for BKK:TM-R:
Capex-to-Revenue: 0.01
GF Value™: ฿2.99 vs. price of ฿2.32 (22.4% below fair value)
No single metric tells the full story. See the BKK:TM-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Techno Medical PCL is a Thailand-based company engaged in the trading business of medical supplies, tools, and equipment. The business activity of the group is import and distribution of operating instruments and disposable supplies, central sterile supply department products, instrument and supply used in laboratory and blood bank, and equipment and tools for heart surgery. Its segments consist of Disposable Equipment and Supplies, Sales of Medical Equipment and Instruments and Services related to Nursing Care. Maximum of revenue is Sales of Disposable Equipment and Supplies.
76GF Score
Get the complete analysis for BKK:TM-R
Capex-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TM-R has been successfully added to your 
